Assembly Biosciences (ASMB) Asset Utilization Ratio (2017 - 2026)
Assembly Biosciences' (ASMB) quarterly Asset Utilization Ratio came in at 0.29 in Q1 2026, down 2.16% year-on-year from 0.29 in Q1 2025, and down 0.77% quarter-over-quarter from 0.29 in Q4 2025.
Assembly Biosciences (ASMB) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Assembly Biosciences' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.29 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 2.16% year-over-year to 0.29 in Q1 2026; TTM through Mar 2026 was 0.29, a 2.16% decrease from a year earlier, with the FY2025 full-year figure at 0.38, up 72.25% from the prior year.
- Asset Utilization Ratio eased to 0.29 in Q1 2026 per ASMB's latest filing, from 0.29 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.37 in Q2 2025 and bottomed at 0.07 in Q1 2023.
- The 4-year median for Asset Utilization Ratio is 0.25 (2024), against an average of 0.21.
- Across the five-year window, Asset Utilization Ratio jumped 241.95% in 2024 and slipped 11.76% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.08 in 2023, then soared by 241.95% to 0.26 in 2024, then increased by 11.8% to 0.29 in 2025, then decreased by 0.77% to 0.29 in 2026.
- Per Business Quant, the three latest ASMB Asset Utilization Ratio figures stand at 0.29 (Q1 2026), 0.29 (Q4 2025), and 0.23 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | 0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.29 |
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.23 |
| Jun 30, 2025 | 0.37 |
| Mar 31, 2025 | 0.29 |
| Dec 31, 2024 | 0.26 |
| Sep 30, 2024 | 0.26 |
| Jun 30, 2024 | 0.18 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 0.08 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.03 |
| Jun 30, 2021 | 0.13 |
| Mar 31, 2021 | 0.27 |
| Dec 31, 2020 | 0.27 |
| Sep 30, 2020 | 0.28 |
| Jun 30, 2020 | 0.17 |
| Mar 31, 2020 | 0.05 |